Literature DB >> 15655459

Lower abdominal bulge after deep inferior epigastric perforator flap (DIEP) breast reconstruction.

Maurice Y Nahabedian1, Bahram Momen.   

Abstract

The etiology of lower abdominal bulge following breast reconstruction with the DIEP flap is uncertain. Most studies report an incidence that ranges from 0.7% to 5%. The purpose of this study was to review a set of factors that may predispose to a lower abdominal bulge. This was a retrospective review of 123 women who had breast reconstruction with the DIEP flap over a 4-year period. The reconstruction was unilateral in 93 women and bilateral in 30 women, totaling 153 flaps. Etiologic factors that were evaluated included patient age, diabetes mellitus, tobacco use, previous abdominal operations, unilateral or bilateral reconstruction, previous childbirth, aponeurotic plication to improve the natural abdominal contour, and use of Marlex mesh. A lower abdominal bulge occurred in 5 of the 123 women (4%), 2 following 30 bilateral reconstructions (6.6%) and 3 following 93 unilateral reconstructions (3.2%). Analysis of the factors for all women demonstrated diabetes mellitus in 1 (0.8%), tobacco use in 9 (7.3%), a prior abdominal operation in 55 (44.7%), previous childbirth in 95 (77%), aponeurotic plication in 49 (40%), and use of Marlex mesh in 4 (3.3%). Statistical analysis did not show any significant association between the explanatory factors and the occurrence of a lower abdominal bulge, except for a weak trend in women who had not been pregnant (P = 0.08). The results of this study demonstrate that the occurrence of a lower abdominal bulge following the DIEP flap is a random event that can occur in anyone. Pregnancy may confer a preventative effect as the collagen fibers strengthen to overcome the stretching forces. Techniques for prevention and treatment include intraoperative assessment of the anterior rectus sheath, use of an adjuvant material for reinforcement if unstable, and vertical plication for bulge repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655459     DOI: 10.1097/01.sap.0000147174.31409.3a

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  A comparison of the superficial inferior epigastric artery flap and deep inferior epigastric perforator flap in postmastectomy reconstruction: A cost-effectiveness analysis.

Authors:  Achilleas Thoma; Leigh Jansen; Sheila Sprague; Eric Duku P Stat
Journal:  Can J Plast Surg       Date:  2008

Review 2.  Achieving ideal donor site aesthetics with autologous breast reconstruction.

Authors:  Maurice Y Nahabedian
Journal:  Gland Surg       Date:  2015-04

3.  Analysis of 461 Consecutive Patients' Donor Site Morbidity following Abdominal Tissue-Based Breast Reconstruction without Fascia Reinforcement Graft.

Authors:  Seong Ae Kim; Daheui Kim; Deuk Young Oh; Jung Ho Lee
Journal:  Biomed Res Int       Date:  2022-02-15       Impact factor: 3.411

4.  The Rectus Abdominis Perforator Turndown Flap for Preserving Rectus Continuity: A DIEP Alternative?

Authors:  Warren M Rozen; Robert Phan; Marc A Seifman; Lisa Ellis; David J Hunter-Smith
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-25

5.  New technical approach for the repair of an abdominal wall defect after a transverse rectus abdominis myocutaneous flap: a case report.

Authors:  Daniel A Kaemmer; Joachim Conze; Jens Otto; Volker Schumpelick
Journal:  J Med Case Rep       Date:  2008-04-16

6.  Lateral Abdominal Wall Defects: The Importance of Anatomy and Technique for a Successful Repair.

Authors:  Benson J Pulikkottil; Ronnie A Pezeshk; Lily N Daniali; Steven H Bailey; Steven Mapula; Ronald E Hoxworth
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-08-18

7.  Age and Overweight Are Not Contraindications for a Breast Reconstruction with a TMG-Flap-A Risk and Complication Analysis of a Retrospective Double Center Study Including 300 Patients.

Authors:  Karl Schwaiger; Laurenz Weitgasser; Maximilian Mahrhofer; Kathrin Bachleitner; Selim Abed; Julia Wimbauer; Elisabeth Russe; Thomas Schoeller; Gottfried Wechselberger
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.